Nobel Biocare
| Nobel Biocare AG
|
|
|---|---|
 |
|
| legal form | Corporation |
| founding | 1981 |
| Seat | Kloten , Switzerland |
| management | Hans Geiselhöringer ( CEO ) Philip Bernard Whitehead ( Chairman of the Board ) |
| Number of employees | 2,487 (December 31, 2013) |
| sales | EUR 566.8 million (2013) |
| Branch | Pharmaceutical technology |
| Website | nobelbiocare.com |
Nobel Biocare is a Swiss company based in Kloten . It is headed by Hans Geiselhöringer. Nobel Biocare is one of the world's largest manufacturers of dental implants.
At a glance
Nobel Biocare is operationally managed from Zurich . The company was founded as Nobelpharma in 1981 and renamed Nobel Biocare in 1996. Nobel Biocare is a pioneer in the field of dental implantology and a world leader in innovative aesthetic dental solutions . The company focuses on the development, production and marketing of dental implants , crowns , bridges as well as veneers and laminates as dental restorations . Nobel Biocare has six production facilities in Sweden , the USA , Canada and Japan . Nobel Biocare has its own sales organizations in 34 countries. The shares of Nobel Biocare Holding AG had until 10 June 2015 the Swiss stock exchange SIX Swiss Exchange listed . Nobel Biocare has a global market share of 35 percent in the dental implant market. The company employs more than 2200 people worldwide and achieved sales of 581.4 million euros in 2009. On September 15, 2014, Danaher Corporation made a takeover bid for Nobel Biocare. The company is valued at CHF 2 billion. In December 2014, Danaher announced that 96.96% of the shares are owned by Danaher. A squeeze-out of the remaining shareholders and a delisting of the shares was requested on January 19, 2015.
history
- 1981 The company Nobel Pharma is Per-Ingvar Brånemark and the Swedish arms manufacturer Bofors founded
- Initiate the development of practical education and training
- 1996 Renamed Nobel Biocare
- 1998 After taking over the American company SteriOss, Nobel Biocare takes on the undisputed leadership position in the field of reconstructive dentistry
- The C & B & I concept (crowns, bridges, implants) simplifies treatment for both the patient and the dentist thanks to integrated solutions.
- 2002 Founding of the new parent company Nobel Biocare Holding AG with headquarters in Zurich, Switzerland and admission to the SWX Swiss Exchange.
- 2005 Nobel Biocare celebrates the 40th anniversary of osseointegration.
- 2014 Danaher takes over Nobel Biocare for CHF 2 billion.
- 2015 squeeze-out and delisting of Nobel Biocare shares.
Web links
Individual evidence
- ↑ a b Nobel Biocare AG: Annual Report 2009 (PDF; 4.0 MB) February 18, 2014, accessed on June 17, 2015 .
- ^ Executive Committee in: Nobel Biocare, accessed May 1, 2011.